References
- Ekbom KA. Restless legs; a report of 70 new cases. Acta Med Scand Suppl 1950;246:64–8.
- Ekbom KA. Restless legs (letter). JAMA 1946;131(5):481.
- Leschziner G, Gringras P. Restless legs syndrome. BMJ 2012;344:e3056.
- Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999;22(7):970–99.
- Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W, et al. A questionnaire study of 138 patients with restless legs syndrome: the ‘Night-Walkers’ survey. Neurology 1996;46(1):92–5.
- Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 2010;11(9):807–15.
- Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med 2011;12(7):623–34.
- Pereira Junior JC, Silva Neto JL, Pradella-Hallinan M. Restless legs syndrome in subjects with a knee prosthesis: evidence that symptoms are generated in the periphery. Clinics (Sao Paulo) 2011;66(11):1955–9.
- Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2011 [Epub ahead of print].
- Trenkwalder C, Hundemer HP, Lledo A, Swieca J, Polo O, Wetter TC, et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 2004;62(8):1391–7.
- Trenkwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW, Tidswell P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75(1):92–7.
- Jones LH. Spontaneous release by positioning. The DO 1964;4:109–16.
- Peters T. Restless legs. Osteopathy Today 2002;8(8):12–13.
- MacDonald R, Peters T, Leach J. A randomised controlled trial of positional release manipulation (counterstrain) in the treatment of restless legs syndrome. Int Musculoskelet Med 2011;33(1):2125.
- Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4(2):101–19.
- Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4(2):121–32.
- Berk M, Ng F, Dodd S, Callaly T, Campbell S, Bernardo M, et al. The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract 2008;14(6):979–83.
- Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319(7211):670–4.
- Allen RP, Ondo WG, Ball E, Calloway MO, Manjunath R, Higbie RL, et al. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med 2011;12(5):431–9.
- Baker WL, White CM, Coleman CI. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med 2008;6(3):253–62.